{
  "@context": "https://schema.org/",
  "@type": "Dataset",
  "id": "nutrient:alpha-lipoic-acid:diabetic-neuropathy:v1",
  "title": "Alpha Lipoic Acid \u2014 Diabetic Neuropathy",
  "category": "metabolic",
  "intervention_type": "supplement",
  "tier": "Silver",
  "label": "PASS",
  "P_effect_gt_delta": 0.799,
  "gate_results": {
    "phi": "PASS",
    "r": 0.87,
    "j": 0.7,
    "k": "PASS",
    "l": "PASS"
  },
  "evidence_summary": {
    "n_studies": 3,
    "total_n": 1082,
    "I2": 36.7,
    "tau2": 0.039,
    "mu_hat": 0.297,
    "mu_CI95": [
      0.135,
      0.446
    ],
    "design_breakdown": {
      "RCT": 0,
      "cohort": 0,
      "other": 3
    }
  },
  "policy_refs": {
    "tel5_levels": "v1.2.0",
    "monte_carlo": "v1.0.1-reml-grid",
    "journal_trust": "2025-10-05"
  },
  "version": "v1",
  "audit_hash": "0x4239f9a6fe0c922d",
  "policy_fingerprint": "0x4d3c2b1a0f9e8d7c",
  "citations_manifest_hash": "sha256:b64ac9b9027dab533db62d0842f7c35b4d1161e2767e0936ca67deb4ae9fdaa2",
  "tier_label_system": "TEL-5",
  "name": "TERVYX Evidence: alpha_lipoic_acid for diabetic_neuropathy",
  "description": "Systematic evidence assessment following TERVYX Protocol v1.0",
  "dateCreated": "2025-11-10T03:15:18.599154+00:00",
  "creator": {
    "@type": "Organization",
    "name": "TERVYX Protocol Consortium"
  },
  "license": "https://creativecommons.org/licenses/by/4.0/"
}